Home β€Ί Stock analysis β€Ί ADVB

Advanced Biomed (ADVB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

ADVB slides 18.4% to $3.98, a 3-month low, 8 down days in a row. Closed at $3.98, -18.44% vs the prior close of $4.88. Day range $3.69–$4.69, opened at $4.69.

Last close$3.98-18.44%
Day range3.69–4.69
Open4.69
Volume28.11K
52-week range3.61–24.23
Avg volume (20d)17.66K

ADVB daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” ADVB slides 18.4% to $3.98, a 3-month low, 8 down days in a row
Oct 15, 2026 β€” ADVB slides 5.1% to $4.88, a 3-month low, 7 down days in a row
Oct 14, 2026 β€” ADVB dips 0.4% to $5.14, a 1-month low, 6 down days in a row
Oct 13, 2026 β€” ADVB dips 2.2% to $5.16, a 1-month low, 5 down days in a row
Oct 12, 2026 β€” ADVB dips 0.7% to $5.28, a 1-month low, 4 down days in a row
Oct 9, 2026 β€” ADVB slides 13.2% to $5.31, a 1-month low, 3 down days in a row
Oct 8, 2026 β€” ADVB dips 1.4% to $6.12, a 1-month low
Oct 7, 2026 β€” ADVB dips 2.7% to $6.21, a 1-month low
Oct 6, 2026 β€” ADVB rises 0.6% to $6.38
Oct 5, 2026 β€” ADVB slides 5.8% to $6.34
Oct 2, 2026 β€” ADVB dips 2.6% to $6.73

ADVB latest news & SEC filings

Every SEC filing by or about ADVB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 13, 2026 Β· Form 10-K β€” Annual report

Annual report (audited full-year financial statements and business review)

Fiscal year ended Jun 30, 2026:

Source: SEC EDGAR filing 0001213900-26-109029

Sep 28, 2026 Β· Form NT 10-K β€” Notice of late annual report

Notice of late annual report

Source: SEC EDGAR filing 0001213900-26-104071

Sep 22, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0002155122-26-000001

Aug 20, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001079973-26-001162

Aug 20, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001079973-26-001160

Aug 20, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001079973-26-001158

Jul 20, 2026 Β· Form RW β€” RW filing

RW filing

Source: SEC EDGAR filing 0001213900-26-079677

Jul 17, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-079233

Jul 1, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-074306

Jun 30, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-073735

Things to know before you trade ADVB

ADVB market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20264.694.693.693.9828.11K
Oct 15, 20265.115.144.884.8810.70K
Oct 14, 20265.265.555.145.1413.70K
Oct 13, 20265.295.305.015.164.80K
Oct 12, 20265.515.515.185.2822.30K
Oct 9, 20266.076.075.315.318.80K
Oct 8, 20266.246.336.106.1221.60K
Oct 7, 20266.576.616.146.2122.40K
Oct 6, 20266.396.746.386.3815.40K
Oct 5, 20266.607.036.346.3415.00K
Oct 2, 20266.977.056.506.7327.10K
Oct 1, 20266.247.126.246.9120.10K
Sep 30, 20266.376.486.236.2314.90K
Sep 29, 20266.626.746.316.3219.50K
Sep 28, 20266.677.236.596.7343.20K
Sep 25, 20266.316.686.316.3812.30K
Sep 24, 20266.356.546.316.318.90K
Sep 23, 20266.416.706.316.3212.40K
Sep 22, 20266.536.776.386.3812.20K
Sep 21, 20266.616.696.286.4719.70K

About Advanced Biomed

Advanced Biomed (ADVB) is listed on the Nasdaq and classified by the SEC under β€œServices-Medical Laboratories”. Its business address is in RENO, NV. State of incorporation: NV. Fiscal year ends June 30. SEC CIK 1941029.

ADVB board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

ADVB financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Jun 30, 2026$127.64K$6.68M5.33$-1.95M
Jun 30, 2025β€”$-3.26M-3.18$-5.83M
Jun 30, 2024β€”$-2.78M-0.14$-2.13M

Latest balance sheet: total assets $13.75M, total liabilities $1.47M, cash $β€” (as of Jun 30, 2026).

ADVB earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Services-Medical Laboratories

Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on ADVB

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.